Hepatocellular carcinoma epidemiology
- PMID: 25260306
- DOI: 10.1016/j.bpg.2014.08.007
Hepatocellular carcinoma epidemiology
Abstract
Primary liver cancer (namely hepatocellular carcinoma, HCC) is worldwide the fifth most common cancer in men and the seventh one in women, and it represents the third most frequent cause of cancer death. HCC rates are particularly high in eastern/south-eastern Asia and in Africa, intermediate in Southern Europe, and low in most high-income countries. Persistent infections by HBV or HCV are the main recognized risk factors for HCC. Aflatoxin exposure is also an important risk factor for HCC development in Africa and eastern Asia. In high-income countries heavy alcohol drinking, tobacco smoking, overweight, diabetes, familial/genetic factors, and selected dietary aspects, have a relevant role. Updated geographic patterns and time trends in mortality from HCC in Europe, USA, Japan, and Australia are provided in the present review, together with an overview of relevant etiologic factors for HCC and main measures for the prevention of this neoplasm.
Keywords: Epidemiology; Hepatitis virus; Hepatocellular cancer; Liver cancer; Risk factors.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Global trends and predictions in hepatocellular carcinoma mortality.J Hepatol. 2017 Aug;67(2):302-309. doi: 10.1016/j.jhep.2017.03.011. Epub 2017 Mar 21. J Hepatol. 2017. PMID: 28336466
-
[Epidemiology of hepatocellular carcinoma].Minerva Gastroenterol Dietol. 1991 Apr-Jun;37(2):73-84. Minerva Gastroenterol Dietol. 1991. PMID: 1660311 Review. Italian.
-
Epidemiological characteristics and risk factors of hepatocellular carcinoma.J Gastroenterol Hepatol. 1997 Oct;12(9-10):S294-308. doi: 10.1111/j.1440-1746.1997.tb00513.x. J Gastroenterol Hepatol. 1997. PMID: 9407350 Review.
-
Disease Burden of Hepatocellular Carcinoma: A Global Perspective.Dig Dis Sci. 2019 Apr;64(4):910-917. doi: 10.1007/s10620-019-05537-2. Dig Dis Sci. 2019. PMID: 30835028 Review.
-
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.Abdom Radiol (NY). 2018 Jan;43(1):13-25. doi: 10.1007/s00261-017-1209-1. Abdom Radiol (NY). 2018. PMID: 28647765 Review.
Cited by
-
Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis.Discov Oncol. 2022 Sep 28;13(1):95. doi: 10.1007/s12672-022-00559-1. Discov Oncol. 2022. PMID: 36171533 Free PMC article. Review.
-
Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy.Int J Mol Sci. 2020 Sep 15;21(18):6757. doi: 10.3390/ijms21186757. Int J Mol Sci. 2020. PMID: 32942580 Free PMC article. Review.
-
Predicting recognition between T cell receptors and epitopes with TCRGP.PLoS Comput Biol. 2021 Mar 25;17(3):e1008814. doi: 10.1371/journal.pcbi.1008814. eCollection 2021 Mar. PLoS Comput Biol. 2021. PMID: 33764977 Free PMC article.
-
Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma.Heliyon. 2023 Nov 9;9(11):e22083. doi: 10.1016/j.heliyon.2023.e22083. eCollection 2023 Nov. Heliyon. 2023. PMID: 38034714 Free PMC article.
-
Identification of key genes and pathways associated with different immune statuses of hepatitis B virus infection.J Cell Mol Med. 2019 Nov;23(11):7474-7489. doi: 10.1111/jcmm.14616. Epub 2019 Sep 29. J Cell Mol Med. 2019. PMID: 31565863 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical